-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...

-The Times of India COIMBATORE: Horticulture production has surpassed production of food grains in the country for the first time and the Central Government is likely to create further growth in horticulture to ensure that the country can access a balanced diet, said agriculturists at the inauguration of the Indian Horticulture Congress here on Thursday. Field crops like rice, wheat and maize contribute to only 30% of the agriculture production in the...

-The Hindu Business Line Now that the gains from the first round have petered out, we need to embrace biotech to boost farm productivity As India seeks to ignite the next agrarian revolution, it must try and absorb some of the lessons of the Green Revolution. Currently, agricultural productivity and growth vary from State to State, resulting in regional disparities. Through targeted policymaking, investment in rural infrastructure and research, and ongoing support...

Despite high prices of fruits and vegetables, India's area under horticultural crops - mainly fruits, vegetables, spices and flowers - has doubled in around twenty years (between 1991-92 and 2012-13). This has resulted in increase in production of horticultural crops nearly threefold (2.8 times). A new report from the Ministry of Agriculture says that the area under horticultural crops during this period rose from 12.77 million hectares to 23.69 million...

-The Indian Express The era of globalised markets is also an era of globalised sovereignties. Nation states must constantly sync their policies with global constituencies of policies and citizens. At times, domestic disharmony is the price nation states may be required and willing to pay. The case in point here is the proposed review of the intellectual property rights (IPR) policy, particularly those clauses that are related to pharmaceutical patent policy....